SCD1 inhibition reduced expression of ALDH1A1, Nanog, and Oct4 in NSCLC [74] and reverted chemo-resistance of BRAFpos melanoma cells [75]. This evidence concerns the gene POU5F1 and non-small cell lung carcinoma.